What is HC Wainwright’s Forecast for ACRV Q3 Earnings?
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Free Report) – Equities researchers at HC Wainwright boosted their Q3 2025 earnings estimates for shares of Acrivon Therapeutics in a research report issued on Thursday, May 15th. HC Wainwright analyst E. Bodnar now expects that the company will earn ($0.52) per share for the quarter, up from their prior […]
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Free Report) – Equities researchers at HC Wainwright boosted their Q3 2025 earnings estimates for shares of Acrivon Therapeutics in a research report issued on Thursday, May 15th. HC Wainwright analyst E. Bodnar now expects that the company will earn ($0.52) per share for the quarter, up from their prior […]
